1. Home
  2. ELTX vs SBFG Comparison

ELTX vs SBFG Comparison

Compare ELTX & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • SBFG
  • Stock Information
  • Founded
  • ELTX 2011
  • SBFG 1983
  • Country
  • ELTX United States
  • SBFG United States
  • Employees
  • ELTX N/A
  • SBFG N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • SBFG Major Banks
  • Sector
  • ELTX Health Care
  • SBFG Finance
  • Exchange
  • ELTX Nasdaq
  • SBFG Nasdaq
  • Market Cap
  • ELTX 121.7M
  • SBFG 132.3M
  • IPO Year
  • ELTX N/A
  • SBFG N/A
  • Fundamental
  • Price
  • ELTX $10.53
  • SBFG $21.00
  • Analyst Decision
  • ELTX Strong Buy
  • SBFG
  • Analyst Count
  • ELTX 2
  • SBFG 0
  • Target Price
  • ELTX $11.00
  • SBFG N/A
  • AVG Volume (30 Days)
  • ELTX 150.1K
  • SBFG 27.3K
  • Earning Date
  • ELTX 08-07-2025
  • SBFG 10-23-2025
  • Dividend Yield
  • ELTX N/A
  • SBFG 2.86%
  • EPS Growth
  • ELTX N/A
  • SBFG 2.59
  • EPS
  • ELTX N/A
  • SBFG 1.83
  • Revenue
  • ELTX N/A
  • SBFG $61,225,000.00
  • Revenue This Year
  • ELTX N/A
  • SBFG N/A
  • Revenue Next Year
  • ELTX N/A
  • SBFG N/A
  • P/E Ratio
  • ELTX N/A
  • SBFG $11.48
  • Revenue Growth
  • ELTX N/A
  • SBFG 9.45
  • 52 Week Low
  • ELTX $3.70
  • SBFG $15.86
  • 52 Week High
  • ELTX $12.42
  • SBFG $24.48
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 54.25
  • SBFG 59.48
  • Support Level
  • ELTX $10.20
  • SBFG $20.50
  • Resistance Level
  • ELTX $12.13
  • SBFG $21.63
  • Average True Range (ATR)
  • ELTX 0.64
  • SBFG 0.66
  • MACD
  • ELTX -0.08
  • SBFG -0.03
  • Stochastic Oscillator
  • ELTX 41.49
  • SBFG 47.66

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About SBFG SB Financial Group Inc.

SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.

Share on Social Networks: